Melodiol Global Health (AU:ME1) has released an update.
Melodiol Global Health has successfully raised $1.1 million through equity placement and loans to fund business growth and corporate expenses, following a 33% revenue increase in the first half of 2024 compared to the previous year. The company issued new shares at a significant discount and drew from a long-term loan facility, signaling potential future capital raising endeavors or asset sales to support its expansion. Melodiol’s commitment to plant-based health products and a recent LOI for a $12 million asset sale reflect its ongoing strategic developments.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.